Program to promote healthy weight gain during pregnancy
Official title: The Effects of Mobile Health Based Lifestyle Intervention on Gestational Weight Gain in Pregnant Women With Overweight and Obesity: A Randomized Controlled Trial
Run by Peking University · NCT06370533 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a program that helps overweight or obese pregnant women gain a healthy amount of weight and avoid gestational diabetes through a mix of online and in-person support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Peking University Academic / other |
| Locations | 2 sites (Beijing, Beijing and 1 other locations) |
| Trial ID | NCT06370533 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are overweight or obese pregnant women aged 18-40, between 8-14 weeks of gestation, who are capable of using smartphones and WeChat.
✕Probably not a fit
Patients with pre-existing severe health conditions or contraindications to physical activity may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program evaluates the effectiveness of a multi-component lifestyle intervention aimed at promoting appropriate gestational weight gain and preventing gestational diabetes mellitus (GDM) among overweight or obese pregnant women. The intervention combines online and offline health education and utilizes mobile health technology through WeChat to engage participants. A total of 200 overweight or obese singleton pregnant women will be recruited and randomly assigned to either the intervention or control group, with follow-up assessments to measure pregnancy and neonatal outcomes. The study is designed to provide insights into effective strategies for managing weight gain during pregnancy.
Why it matters
Potential benefit: If successful, this program could lead to healthier pregnancy outcomes and reduce the risk of complications associated with excessive weight gain.
How similar studies have gone: Previous studies have shown that lifestyle interventions can be effective in managing weight during pregnancy, but the specific mobile health approach in this study is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. At 8-14 weeks of gestation 2. Overweight or obese (pre-pregnancy 40 kg/m2≥BMI≥24 kg/m2) based on BMI recommendations of the Group of China Obesity Task Force of the Chinese Ministry of Health accounting for interracial differences (overweight BMI 24-28 kg/m2 and obese BMI≥28kg/m2) 3. 18-40 years of age 4. Singleton pregnant 5. Skilled at using smartphones and WeChat during pregnancy 6. Attend regular antenatal care and plan delivery at W.F. Maternal and Child Health Hospital or Tongzhou Maternal and Child Health-care Institution of Beijing 7. No contraindications to physical activity according to Physical Activity Readiness Questionnaire (PAR-Q) 8. Willing to be randomized and cooperate with research and regular follow-up visits and sign informed consent. Exclusion Criteria: 1. Pre-pregnancy hypertension, severe cardiovascular and cerebrovascular diseases, respiratory disease, hepatic and renal disease, malignant tumors, systemic lupus erythematosus, thyroid disease, severe anemia, and other chronic consumptive diseases. 2. Cervical insufficiency (historical painless cervical dilation leading to recurrent second-trimester births in the absence of other causes; dilated cervix on manual or speculum examination, etc.), multiple pregnancy, or continuous vaginal bleeding, etc. 3. Diabetes before pregnancy 4. Special dietary needs (e.g. , vegetarianism) 5. Severe psychiatric disorders (serious mental health disorders including depression, anxiety, bipolar disorders, etc.) 6. Cognitive impairment, visual impairment or hearing impairment 7. History of bariatric surgery or surgical history involving important organs within 3 months 8. Participated in other clinical trials within 6 months
Where it's running
-
W.F. Maternal and Child Health Hospital;
Weifang, Shandong, China Recruiting -
Tongzhou Maternal and Child Health-care Institution
Beijing, Beijing, China Not yet recruiting
Study contacts
- Principal investigator: Haixue Wang, Doctor — Peking University
- Study coordinator: Haixue Wang, Doctor
- Email: gwwanghaixue@126.com
- Phone: 13041196856
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Managing weight gain during pregnancy with a new digital intervention
This study is testing a new digital program to help pregnant women who are overweight or obese manage their weight gain during pregnancy.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
Gestational weight gain and outcomes after preconception GLP-1 receptor agonist use
This observational study looks to see if moms who used GLP-1 medications before pregnancy have different weight gain during pregnancy and pregnancy outcomes than those who didn’t use GLP-1 medications.
-
MR-based performance tests for overweight and obesity
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
-
DA-302168S in adults with overweight or obesity
A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.